Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
TLN_April2022_p342_354 (pdf)
The Lancet Neurology April2022 p342_354 (online)
from The Lancet Neurology
Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
TLN_April2022_p342_354 (pdf)
The Lancet Neurology April2022 p342_354 (online)
from The Lancet Neurology
www.prionalliance.org
Prion Alliance is a 501(c)(3) non-profit devoted to funding research towards a treatment or cure for human prion disease.
macholevante.com
Unlocking the Hidden Phase: How Prion Disease Latency Diagnostics Are Transforming Early Detection in 2025. Explore the Technologies, Market Forces, and Future Outlook Shaping This Critical Field. Exe...
© 2025 CJD Support Group Network Australia.
The CJDSGN acknowledges the funding provided by the Department of Health
that assists towards the cost of this website.
Disclaimer Privacy Policy